Intrinsic Value of S&P & Nasdaq Contact Us

American Healthcare REIT, Inc. AHR NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
$18.29
-62.5%
Analyst Price Target
$53.33
+9.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

American Healthcare REIT, Inc. (AHR) trades at a trailing P/E of 115.8, forward P/E of 65.2. Trailing earnings yield is 0.86%, forward earnings yield 1.53%. PEG 0.83 (Peter Lynch undervalued ≤1.0). Graham Number is $13.84.

Criteria proven by this page:

  • VALUE (42/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 65.2 (down from trailing 115.8) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.83 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 0.86% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 1.53% as earnings recover.
  • Analyst consensus target $53.33 (+9.2% upside) — modest upside expected.

Overall SharesGrow Score: 50/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
~
VALUE
42/100
Price-to-Earnings & upside
Proven by this page
FUTURE
88/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
24/100
→ Income
GROWTH
90/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — AHR

Valuation Multiples
P/E (TTM)115.8
Forward P/E65.2
PEG Ratio0.83
Forward PEG0.83
P/B Ratio2.43
P/S Ratio4.05
EV/EBITDA33.1
Per Share Data
EPS (TTM)$0.42
Forward EPS (Est.)$0.75
Book Value / Share$20.24
Revenue / Share$13.61
FCF / Share$1.36
Yields & Fair Value
Earnings Yield0.86%
Forward Earnings Yield1.53%
Dividend Yield2.05%
Graham Number$13.84
SharesGrow IV$18.29 (-62.5%)
Analyst Target$53.33 (+9.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -4.4 0.00 0.51 0.65 8.05%
2017 58.4 -0.54 0.55 0.62 8.51%
2018 49.7 2.86 0.62 0.58 9.08%
2019 -121.1 0.86 0.67 0.49 10.41%
2020 403.7 -3.11 1.01 0.74 3.09%
2021 -18.3 0.01 0.55 0.69 2.60%
2022 -10.8 -0.15 0.63 0.54 5.84%
2023 -12.2 1.00 0.69 0.47 8.74%
2024 -98.2 1.34 1.64 1.79 3.26%
2025 111.9 -0.46 2.35 3.46 2.09%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.13 $3.1M $-6.35M -205%
2017 $0.29 $46.87M $14.16M 30.2%
2018 $-0.17 $84.35M $-8.58M -10.2%
2019 $-0.41 $120.77M $-18.77M -15.5%
2020 $0.09 $1.19B $2.16M 0.2%
2021 $-0.79 $1.27B $-47.79M -3.8%
2022 $-1.10 $1.62B $-81.3M -5%
2023 $-1.08 $1.86B $-71.47M -3.8%
2024 $-0.29 $2.07B $-37.81M -1.8%
2025 $0.42 $2.26B $69.81M 3.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.78 $0.73 – $0.81 $2.63B $2.38B – $3.09B 3
2027 $1.02 $0.93 – $1.07 $3.07B $2.53B – $3.78B 3
2028 $1.28 $1.12 – $1.57 $3.08B $3B – $3.16B 1
2029 $1.62 $1.42 – $1.99 $3.33B $3.01B – $3.92B 1
2030 $0.00 $0.00 – $0.00 $3.86B $3.49B – $4.53B 0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message